Poseida Therapeutics Inc

-0.12 (-2.28%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)321.29M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$30.83 Million
Adjusted EPS-$0.23
See more estimates
10-Day MA$5.91
50-Day MA$6.80
200-Day MA$7.99
See more pivots

Poseida Therapeutics Inc Stock, NASDAQ:PSTX

9390 Towne Centre Drive, Suite 200, San Diego, California 92121
United States of America
Phone: +1.858.779.3100
Number of Employees: 206


Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.